About Jubilant Generics Limited
Data last updated:
Jubilant Generics Limited is a public limited foreign company incorporated in india based in Noida, Uttar Pradesh, India, a subsidiary of Jubilant Pharmova Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2013FLC060821. Its GSTIN is 09AADCJ2401L1ZO (Uttar Pradesh). The company holds 12 GST registrations, all of them active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.58 Cr. It is led by directors including Jaidev Sanjeev Rajpal (Managing Director) and Gayatri Taragi.
Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 1A Sector 16A Institutional Area Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2023, the company reported a revenue of ₹326.62 Cr, a decline of 75% compared to the previous year. For the same year it recorded a net loss of ₹188.76 Cr (net margin -57.8%) and EBITDA of -₹103.3 Cr (EBITDA margin -31.6%). Revenue has declined at a compounded annual rate (CAGR) of 35% over three years and 20% over five years.
The company has about 1,106 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Jubilant Generics. As per MCA filings, the company has open charges of ₹500 Cr and satisfied charges of ₹810 Cr on record. Court records list 23 cases involving the company, including 7 filed by the company and 14 filed against it; 9 cases are pending. The company has 4 deals on record (2 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹2,078.07 Cr; the latest was in October 2016. The company has 3 MSME Form 1 returns on record between 2022 and 2023, listing 692 overdue payments to 165 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jubilantgenerics.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot 1A Sector 16A Institutional Area Noida, Uttar Pradesh, India – 201301
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Jubilant Generics Limited FY 2025 filings available
Jubilant Generics Limited reported revenue of ₹326.62 Cr (down 75% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Jubilant Generics Limited
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 75% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Jubilant Generics Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹326.62 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹103.3 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹188.76 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Jubilant Generics Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -31.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -57.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jubilant Generics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Jubilant Generics Limited
Jubilant Generics Limited is audited by B S R & Co. LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Jubilant Generics Limited
Jubilant Generics has 3 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gayatri Taragi Also directs: Jubilant Agro Sciences Limited, Jubilant Biosys Limited | Director | 21 May 2024 | 2 Years 4 Months | Current |
| Jaidev Sanjeev Rajpal | Managing Director | 11 Oct 2022 | 4 Years 0 Months | Current |
| Shirish Gundopant Belapure Also directs: Bellapure Onco Phytoceuticals LLP, Jubilant Pharmova Limited, Corona Remedies Limited and 3 more | Director | 20 Jun 2024 | 2 Years 3 Months | Current |
Ownership and Shareholding of Jubilant Generics Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Jubilant Generics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jan 2015 | Others | ₹500 Cr | Open |
| 05 Feb 2016 | Indusind Bank Ltd. | ₹100 Cr | Satisfied |
| 30 Sep 2014 | Il & Fs Trust Company Limited | ₹130 Cr | Satisfied |
| 23 Sep 2014 | Export Import Bank of India | ₹30 Cr | Satisfied |
| 30 Jul 2014 | The Ratnakar Bank Limited | ₹50 Cr | Satisfied |
Total charge records: 8 View all charges
Deals & Funding of Jubilant Generics Limited
Jubilant Generics Limited has 4 deals on record (2 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹2,078.07 Cr; the latest was in October 2016.
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Jubilant Generics Limited
Jubilant Generics Limited has 23 court cases on record: 7 filed by Jubilant Generics, 14 filed against it, 2 where it is another party. 9 cases are pending and 14 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 9 | 7 |
| District courts | 6 | 4 | 2 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed by the company against Texas Biolabs Private Limited | Pending |
| Allahabad High Court | Court case (A227) | Filed against the company by Medreich Limited | Disposed |
| Allahabad High Court | Court case (A227) | Filed against the company by Jamp India Pharmaceuticals Private Limited | Disposed |
| Allahabad High Court | Court case (FAFOD) | Filed against the company by Jamp India Pharmaceuticals Private Limited | Disposed |
| Allahabad High Court | Court case (COPL) | Filed against the company by Jamp India Pharmaceuticals Private Limited | Disposed |
Full case history
All 23 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Jubilant Generics Limited
Jubilant Generics Limited has 3 MSME Form 1 returns on record between 2022 and 2023, listing 692 overdue payments to 165 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 165)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Benchmark Esg Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Glatt (India) Engineering Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Jubilant Generics Limited
Jubilant Generics operates one associated brand: Jubilant Generics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Focuses on R&D and manufacturing of drugs for various therapeutic areas. | jubilantgenerics.com |
Employees and EPFO Compliance at Jubilant Generics Limited
Jubilant Generics Limited has a workforce of 1,106 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Jubilant Generics Limited
Jubilant Generics Limited has 26 board changes on record since 2015: 5 appointments and 21 cessations. The latest: Gayatri Taragi ceased to be Additional Director on 29 Sep 2024.
35 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Jubilant Generics Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jubilant Generics Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Jubilant Generics Limited
Jubilant Generics has 12 GST registrations: 12 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCJ2401L1ZO | Uttar Pradesh | Active | 01 Jul 2017 |
| 09AADCJ2401L7ZI | Uttar Pradesh | Active | 13 Jul 2017 |
| 05AADCJ2401L1ZW | Uttarakhand | Active | 01 Jul 2017 |
| 29AADCJ2401L1ZM | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jubilant Generics Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Jubilant Generics Limited
Frequently Asked Questions about Jubilant Generics Limited
Jubilant Generics is an active public limited foreign company incorporated in india based in Noida, Uttar Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 November 2013 (13+ years old) and is registered under CIN U24100UP2013FLC060821.
Jubilant Generics reported revenue of ₹326.62 Cr for FY 2023 (down 75% YoY).
Jubilant Generics has 3 current directors:
- Jaidev Sanjeev Rajpal - Managing Director
- Gayatri Taragi - Director
- Shirish Gundopant Belapure - Director
Jubilant Generics reported a net loss of ₹188.76 Cr (net margin -57.8%) and EBITDA of -₹103.3 Cr (EBITDA margin -31.6%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Jubilant Generics is -35% over three years and -20% over five years. In the latest year (FY 2023) revenue fell 75%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Jubilant Generics is 09AADCJ2401L1ZO, registered in Uttar Pradesh. The company has 12 GST registrations in all, of which 12 are active. Other active GSTINs include 09AADCJ2401L7ZI (Uttar Pradesh), 05AADCJ2401L1ZW (Uttarakhand), 29AADCJ2401L1ZM (Karnataka).
The CIN (Corporate Identification Number) of Jubilant Generics is U24100UP2013FLC060821. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jubilant Generics has 23 court cases on record: 7 filed by the company and 14 filed against it. 9 are pending. Most are in the high courts.
Jubilant Generics was incorporated on 25 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Jubilant Generics has 4 deals on record (2 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹2,078.07 Cr; the latest was in October 2016.
Gayatri Taragi ceased to be Additional Director on 29 Sep 2024. Shirish Gundopant Belapure ceased to be Additional Director on 29 Sep 2024. Shirish Gundopant Belapure was appointed as Director on 20 Jun 2024. Jubilant Generics has 26 board changes on record in total.